New drug CT1812 tested for lewy body dementia
Disease control
Completed
This study tested a drug called CT1812 in 130 people with mild to moderate Dementia with Lewy Bodies. The goal was to see if the drug is safe and if it can help with symptoms like thinking and sleepiness. Participants received either the drug or a placebo for 6 months, and resear…
Phase: PHASE2 • Sponsor: Cognition Therapeutics • Aim: Disease control
Last updated May 17, 2026 18:21 UTC